Institute for Biocomplexity and Informatics, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Bioorg Med Chem. 2011 Feb 15;19(4):1381-9. doi: 10.1016/j.bmc.2011.01.016. Epub 2011 Jan 14.
Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates.
碳酸酐酶(CAs,EC 4.2.1.1)可被磺胺类药物、无机阴离子、酚类、香豆素(作为前药)和多胺抑制。本文报道了一类新型碳酸酐酶抑制剂(CAIs),它们以不同的方式与 CA 同工酶 I、II(细胞溶质)和 IX、XII(跨膜,肿瘤相关)相互作用。动力学测量允许我们鉴定羟基/甲氧基取代的苯甲酸以及二/三甲氧基苯作为四种 CA 同工酶的亚微摩尔-低微摩尔抑制剂。对一组此类抑制剂在 CA I 和 II 内的分子对接研究使我们能够理解抑制机制。与迄今为止已知的所有其他类抑制剂相比,这种新型抑制剂的结合方式不同:它们位于酚结合位点和香豆素结合位点之间,从而填充了酶腔的中间部分。与其他类抑制剂相比,它们与 CA 活性位点的氨基酸残基和水分子之间存在不同的相互作用,这为设计与临床使用的磺胺类/磺胺酸盐相比具有有趣抑制谱的 CAIs 提供了可能性。